Clinical Trial

Observational Study on Therapy Pathways of Asthamics Treated With ICS/LABA/LAMA Therapy in a Real-world Setting

Study acronym: TRIMAXIMIZE
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 1, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
TriMaximize is a non-interventional study aimed to collect prospective data from asthmatic patients under routine care, for whom their treating physician has decided to prescribe BDP/FF/G (beclomethasone/formoterol/glycopyrronium).
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-10-24; most recent amendment 2025-06-26.
Status change: Recruiting → Active, Not Recruiting 2025-06-26
Status change: Not Yet Recruiting → Recruiting 2024-06-17
Trial Details
NCT Number NCT06100042
Lead Sponsor Chiesi Italia
Collaborators: Gesellschaft für Therapieforschung mbH
Conditions Asthma
Enrollment 200 participants
Start Date 2024-04-24
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-01